《生命科学》 2020, 32(2): 195-202
摘 要:摘 要:糖尿病足溃疡(diabetic foot ulcer, DFU) 是糖尿病主要并发症之一。微小RNA (microRNA, miRNA)是一种在转录后水平调控基因表达的、内源性、非编码单链小RNA。近年来的研究表明,miRNA 与DFU的炎症调控、血管新生、再上皮化等过程密切相关。MiRNA 靶向治疗的体外和体内实验研究展现出了miRNA 未来潜在的治疗价值。现就miRNA 在DFU 创面愈合的各阶段中的调控作用及其治疗应用的可能性两方面进行综述,为后续研究开拓新的思路。
Abstract: Abstract: MicroRNA (miRNA) is a group of endogenous non-coding single-stranded small RNA which regulates gene expression at the post-transcriptional level. Recent studies have suggested that miRNA plays an important role in inflammation, angiogenesis, and re-epithelialization in the impaired wound healing process of diabetic foot ulcer (DFU). MiRNA-targeted therapeutics showed promising potentialities of treatment in the future based on plenty of researches. The objective of this review is to summarize the regulatory effects on wound healing of miRNA and its therapeutic potentialities in the treatment of DFU, shedding a light on the future.